Search for: "Mylan Pharmaceuticals v. FDA"
Results 41 - 60
of 233
Sort by Relevance
|
Sort by Date
3 Jun 2016, 6:40 am
Cordis Corporation, et al., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
18 May 2016, 8:19 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
3 May 2016, 9:00 pm
Their practices emphasize pharmaceutical patent counseling, patent procurement, and patent litigation. [2] Acorda Therapeutics Inc. et al. v. [read post]
3 May 2016, 1:42 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 Apr 2016, 9:58 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 Mar 2016, 2:04 pm
Mylan Pharmaceuticals, Inc., 78 F. [read post]
17 Mar 2016, 2:45 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
19 Feb 2016, 11:57 am
Brown v. [read post]
1 Feb 2016, 10:43 am
Atlas Powder Co. v. [read post]
13 Nov 2015, 4:54 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
3 Jun 2015, 9:55 am
In December 2002, when generic manufacturers Teva, Ranbaxy, Mylan and Barr sought permission from the FDA pursuant to the Hatch-Waxman Act to market a generic version of Provigil, Cephalon sued the four companies for patent infringement. [read post]
14 Apr 2015, 8:34 pm
Apotex Inc. v. [read post]
14 Apr 2015, 8:34 pm
Apotex Inc. v. [read post]
25 Mar 2015, 4:42 am
See also JHP Pharmaceuticals, LLC v. [read post]
7 Nov 2014, 5:52 am
Millions more use drugs and medical devices even though they carry the FDA’s strongest “black box” warnings. [read post]
13 Oct 2014, 9:01 am
Wednesday, the Supreme Court will hold one hour of oral argument on a high-stakes legal battle between a brand-name drug company and a group of companies making generic drugs – Teva Pharmaceuticals USA v. [read post]
10 Oct 2014, 1:16 pm
JHP Pharmaceuticals, LLC v. [read post]
25 Aug 2014, 8:57 am
This act then triggers a 30-month stay of FDA approval and the ANDA. [read post]
